Infrastructure-1440

Transactional Services

Our Corporate lawyers work alongside all stakeholders as enablers, creating the best environment to help you through complexity to unlock value and achieve your corporate strategy.

Please select

Out-Law / Your daily need to know in Transactional Services

We act for a wide range of blue-chip clients

ranking among the top five law firms in the world by number of PLC clients

We are a Tier 1 firm in numerous areas of practice

Including for Mid-market M&A and Small & Mid-cap flotations (London) in the Legal 500 UK 2018

We provide a full range of advisory services

With market-leading practices in corporate, commercial, EU & competition, employment and tax 

Our latest work

Our advisers act on domestic and international matters of all shapes and sizes, working with many of the leading names in the market. Browse our experience below, or use the filters to look-up recent work in particular geographies and industry sectors.

    Our expertise, at your disposal

    With over 430 partners and 3000 people around the world, we are well-placed to support you across a full range of legal and advisory services.

    Latest press releases

    Show me all press releases

    Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

    Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

    Pinsent Masons advises on Four Seasons Care Homes portfolio migration

    Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

    Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

    Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).